280 related articles for article (PubMed ID: 34679477)
21. Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995-2019.
Capuano I; Garofalo C; Buonanno P; Pinelli M; Di Risi T; Feriozzi S; Riccio E; Pisani A
J Nephrol; 2020 Jun; 33(3):569-581. PubMed ID: 31650418
[TBL] [Abstract][Full Text] [Related]
22. Screening for Fabry Disease in Young Strokes in the Australian Stroke Clinical Registry (AuSCR).
Malavera A; Cadilhac DA; Thijs V; Lim JY; Grabsch B; Breen S; Jan S; Anderson CS
Front Neurol; 2020; 11():596420. PubMed ID: 33324335
[No Abstract] [Full Text] [Related]
23. Multidisciplinary approach to screening and management of children with Fabry disease: practice at a Tertiary Children's Hospital in China.
Shen Q; Liu J; Chen J; Zhou S; Wang Y; Yu L; Sun L; Wang L; Wu B; Liu F; Cao Y; Huang Y; Wang J; Yang C; Zhu D; Ma Y; Xu Z; Lu W; Fu L; Zhou W; Xu H
Orphanet J Rare Dis; 2021 Dec; 16(1):509. PubMed ID: 34906154
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.
Jahan S; Sarathchandran S; Akhter S; Goldblatt J; Stark S; Crawford D; Mallett A; Thomas M
Orphanet J Rare Dis; 2020 Jan; 15(1):10. PubMed ID: 31931840
[TBL] [Abstract][Full Text] [Related]
25. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility of urinary mulberry bodies/cells testing in the diagnosis of Fabry disease.
Nakamura K; Mukai S; Takezawa Y; Natori Y; Miyazaki A; Ide Y; Takebuchi M; Nanato K; Katoh M; Suzuki H; Sakyu A; Kojima T; Kise E; Hanafusa H; Kosho T; Kuwahara K; Sekijima Y
Mol Genet Metab Rep; 2023 Sep; 36():100983. PubMed ID: 37323223
[TBL] [Abstract][Full Text] [Related]
27. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
28. A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance.
van der Tol L; Smid BE; Poorthuis BJ; Biegstraaten M; Deprez RH; Linthorst GE; Hollak CE
J Med Genet; 2014 Jan; 51(1):1-9. PubMed ID: 23922385
[TBL] [Abstract][Full Text] [Related]
29. Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.
Oliveira JP; Nowak A; Barbey F; Torres M; Nunes JP; Teixeira-E-Costa F; Carvalho F; Sampaio S; Tavares I; Pereira O; Soares AL; Carmona C; Cardoso MT; Jurca-Simina IE; Spada M; Ferreira S; Germain DP
Eur J Med Genet; 2020 Feb; 63(2):103703. PubMed ID: 31200018
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and Screening of Patients with Fabry Disease.
Vardarli I; Rischpler C; Herrmann K; Weidemann F
Ther Clin Risk Manag; 2020; 16():551-558. PubMed ID: 32606714
[TBL] [Abstract][Full Text] [Related]
31. Screening for Fabry disease among 619 hemodialysis patients in Saudi Arabia.
Alhemyadi SA; Elawad M; Fourtounas K; Abdrabbou Z; Alaraki B; Younis S; Nawaz Z; Alqurashi S; Mohamed S
Saudi Med J; 2020 Aug; 41(8):813-818. PubMed ID: 32789421
[TBL] [Abstract][Full Text] [Related]
32. A novel double
Hirose M; Okada S; Kobayashi Y
Mol Genet Metab Rep; 2023 Sep; 36():100982. PubMed ID: 37332487
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females.
Stiles AR; Zhang H; Dai J; McCaw P; Beasley J; Rehder C; Koeberl DD; McDonald M; Bali DS; Young SP
Mol Genet Metab; 2020 Jul; 130(3):209-214. PubMed ID: 32418857
[TBL] [Abstract][Full Text] [Related]
34. Cost Efficacy of α-Galactosidase A Enzyme Screening for Fabry Disease.
Newman DB; Miranda WR; Matern D; Peck DS; Geske JB; Maleszewski JJ; Ommen SR; Ackerman MJ
Mayo Clin Proc; 2019 Jan; 94(1):84-88. PubMed ID: 30611458
[TBL] [Abstract][Full Text] [Related]
35. α-Galactosidase A/lysoGb3 ratio as a potential marker for Fabry disease in females.
Baydakova GV; Ilyushkina AA; Moiseev S; Bychkov IO; Nikitina NV; Buruleva ТА; Zakharova EY
Clin Chim Acta; 2020 Feb; 501():27-32. PubMed ID: 31770509
[TBL] [Abstract][Full Text] [Related]
36. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
[TBL] [Abstract][Full Text] [Related]
37. Frequency of Fabry disease in chronic kidney disease patients including patients on renal replacement therapy in Korea.
Cho E; Park JT; Yoo TH; Kim SW; Park CW; Han SS; Kim YH; Kwon YJ
Kidney Res Clin Pract; 2024 Jan; 43(1):71-81. PubMed ID: 38213034
[TBL] [Abstract][Full Text] [Related]
38. An Atypical Cardiac Manifestation of Fabry Disease from a Novel Pathological Variant on the GLA Gene.
Sarsam L; Arouni A; Mahfood Haddad T; Onaiwu CO; Erickson C
Cureus; 2020 Mar; 12(3):e7262. PubMed ID: 32292674
[TBL] [Abstract][Full Text] [Related]
39. Functional studies of new GLA gene mutations leading to conformational Fabry disease.
Filoni C; Caciotti A; Carraresi L; Cavicchi C; Parini R; Antuzzi D; Zampetti A; Feriozzi S; Poisetti P; Garman SC; Guerrini R; Zammarchi E; Donati MA; Morrone A
Biochim Biophys Acta; 2010 Feb; 1802(2):247-52. PubMed ID: 19941952
[TBL] [Abstract][Full Text] [Related]
40. Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic.
Reková P; Dostálová G; Kemlink D; Paulasová Schwabová J; Dubská Z; Vaneckova M; Mašek M; Kodet O; Poupětová H; Mazurová S; Rajdova A; Vlckova E; Táboříková A; Fafejtová Š; Nevsimalova M; Linhart A; Tomek A
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
